Eastman Chemical (EMN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.97
- EPS estimate
- $1.82
- EPS surprise
- +8.26%
- Revenue surprise
- +4.82%
- Revenue
- $2.5B
- Revenue estimate
- $2.4B
- Reported
- Jul 30, 2026
Eastman reported Q2 2026 results on July 30, 2026. Earnings per share were $1.97, ahead of the $1.82 estimate by 8.26%. Revenue was $2.5 billion, above the $2.4 billion consensus by 4.82%. Compared with Q2 2025, EPS rose about 23% from $1.60 and revenue rose from $2.3 billion. The quarter also extended a recovery from Q4 2025, when EPS fell to $0.75, the lowest in the table.
The longer record is uneven. Annual EPS was $7.83 in 2022, $6.40 in 2023 and $7.89 in 2024, then fell about 32% to $5.40 in 2025. Quarterly revenue ran at $2.7 billion to $2.8 billion from Q3 2021 to Q3 2022 and has stayed between $2.0 billion and $2.5 billion since. The highs in the table, $2.83 per share and $2.8 billion in revenue, both came in Q2 2022. Eastman beat the EPS estimate in 14 of the last 20 quarters and in 6 of the last 8.
Eastman reported Q3 between October 26 and November 3 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the rebound in quarterly EPS holds.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $1.82 | $1.97 | +8.26% | $2.5B | SEC |
| Q1 2026 | Apr 30, 2026 | $1.06 | $1.09 | +2.47% | $2.2B | SEC |
| Q4 2025 | Jan 29, 2026 | $0.72 | $0.75 | +4.14% | $2.0B | SEC |
| Q3 2025 | Nov 3, 2025 | $1.16 | $1.14 | −1.56% | $2.2B | SEC |
| Q2 2025 | Jul 31, 2025 | $1.73 | $1.60 | −7.39% | $2.3B | SEC |
| Q1 2025 | Apr 24, 2025 | $1.89 | $1.91 | +0.94% | $2.3B | SEC |
| Q4 2024 | Jan 30, 2025 | $1.57 | $1.87 | +18.80% | $2.2B | SEC |
| Q3 2024 | Oct 31, 2024 | $2.15 | $2.26 | +5.06% | $2.5B | SEC |
| Q2 2024 | Jul 25, 2024 | $2.01 | $2.15 | +6.83% | $2.4B | SEC |
| Q1 2024 | Apr 25, 2024 | $1.43 | $1.61 | +12.34% | $2.3B | SEC |
| Q4 2023 | Feb 1, 2024 | $1.30 | $1.31 | +1.10% | $2.2B | SEC |
| Q3 2023 | Oct 26, 2023 | $1.44 | $1.47 | +1.82% | $2.3B | SEC |
| Q2 2023 | Jul 27, 2023 | $1.93 | $1.99 | +2.90% | $2.3B | SEC |
| Q1 2023 | Apr 27, 2023 | $1.25 | $1.63 | +30.42% | $2.4B | SEC |
| Q4 2022 | Jan 26, 2023 | $1.25 | $0.89 | −29.07% | $2.4B | SEC |
| Q3 2022 | Oct 27, 2022 | $2.03 | $2.05 | +0.95% | $2.7B | SEC |
| Q2 2022 | Jul 28, 2022 | $2.68 | $2.83 | +5.62% | $2.8B | SEC |
| Q1 2022 | Apr 28, 2022 | $2.11 | $2.06 | −2.49% | $2.7B | SEC |
| Q4 2021 | Jan 27, 2022 | $1.87 | $1.81 | −3.25% | $2.7B | SEC |
| Q3 2021 | Oct 28, 2021 | $2.46 | $2.46 | −0.02% | $2.7B | SEC |
Quarterly revenue
Frequently asked questions
When did Eastman Chemical (EMN) last report earnings?
Eastman Chemical last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did EMN beat earnings estimates?
Yes. Eastman Chemical reported EPS of $1.97 for Q2 2026 against a $1.82 estimate — a 8.26% beat.
How much revenue did EMN report last quarter?
Eastman Chemical reported $2.5B in revenue for Q2 2026, against a consensus estimate of $2.4B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.